Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.
about
Influenza virus antigenic variation, host antibody production and new approach to control epidemicsA critical role for OX40 in T cell-mediated immunopathology during lung viral infectionPersistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARSMechanisms of Cross-protection by Influenza Virus M2-based VaccinesHost Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza PandemicLive Imaging of Influenza Infection of the Trachea Reveals Dynamic Regulation of CD8+ T Cell Motility by AntigenPulmonary infection with influenza A virus induces site-specific germinal center and T follicular helper cell responsesPeripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza VirusThe aryl hydrocarbon receptor: differential contribution to T helper 17 and T cytotoxic 17 cell developmentInfluenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profilingRole for phospholipid acyl chains and cholesterol in pulmonary infections and inflammationRSV-specific anti-viral immunity is disrupted by chronic ethanol consumptionInvariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humansFunctional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice techniqueA synthetic adjuvant to enhance and expand immune responses to influenza vaccinesControl of influenza virus infection by immunity to conserved viral features.Primary and long-term B-cell responses in the upper airway and lung after influenza A virus infection.Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus.Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin.Influenza A virus infection kinetics: quantitative data and models.Changes in cytokine levels and NK cell activation associated with influenza.Enhanced Tim3 activity improves survival after influenza infectionProliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infectionSub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.A detailed analysis of the murine TAP transporter substrate specificityBaseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice.Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adultsPreferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Identification of a unique population of tissue-memory CD4+ T cells in the airways after influenza infection that is dependent on the integrin VLA-1.Dissecting the host response to a gamma-herpesvirus.The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c miceCharacterization of gammaherpesvirus 68 gene 50 transcriptionThe role of alpha/beta and gamma interferons in development of immunity to influenza A virus in miceEffect of influenza A infection on maturation and function of neonatal monocyte-derived dendritic cellsConcerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection.
P2860
Q21245119-952D7590-D50D-4103-A70B-467FAA4FD4D1Q24672415-F1ACB506-A83D-4962-B366-E4933905FA80Q24811607-9FB9F999-54B0-4033-AAEF-4BDB5C53887AQ26777740-39C45C73-A657-46D4-B2C4-6710B5A6D512Q26782795-52C7D9B8-B18C-4090-9D27-24A59CE05DDCQ27312029-DC3ED427-428E-4D58-935B-872ABE0D4FA3Q27334210-8E2A0ED1-5A27-473A-94FB-B384CA7A06D7Q27336918-5D7FA313-9EB1-47B0-9600-637BA7068107Q27348969-B30A821C-145B-4972-B96A-3CF937F15FC8Q28270978-03FC62A7-D96D-4BF8-8DA4-FC7244A9C23EQ28391857-C15DE239-806B-497B-A3D2-F10B5202E694Q28394949-51A5C997-1A49-4C89-9B70-2787D195E12EQ28511526-B9837A23-3041-45D0-98F9-60B67274FC8CQ28535298-62E6B76D-BA60-4E25-990E-7348E15ACE7CQ28748680-E4937714-98C8-4300-BFB5-27D04396A325Q30343902-E51D41AB-4B0B-4FD1-8D67-E630B4E9B377Q30362668-3F5141E6-81CA-43E3-920B-69F37C9CF47FQ30374900-C6DC78A9-418F-4CA9-A32D-CC288BEEC936Q30375496-6950B0D1-ECF5-4D19-AE83-5B5D5D042A33Q30388405-A108F04C-CFD9-4F1B-9814-1CA9EC7C6993Q30390932-7A2BFFDE-7A91-45DB-9305-38C214FA8923Q30393406-D32C3077-B53F-4E4D-9FB1-22796163BC39Q30398031-7C7DABEB-7B0F-458B-A908-67C1BD24B834Q30407695-31AC5AE7-25F8-4DE1-97A0-353FF51312C3Q30420186-F7449619-BF59-4F0D-8F14-2D0F962CAE29Q30436432-0D8CB64F-747B-4844-9EAC-ED6D1D825166Q33323372-C86301B9-89AC-4616-8F96-7F1E31F0CFB7Q33342843-750A366A-D6F5-44CC-B899-0F5513053486Q33348541-992C1ED2-B64A-4F77-8006-A4C9A77E7274Q33511964-46D64E5B-C42D-4DA7-BC8F-6E69386D5454Q33567685-B16AE2D8-5BD6-4A04-9A95-70AB42985921Q33593103-EDC62F0E-B1E5-4983-B70B-3510E48B1DACQ33676552-3E1D36E8-6100-4024-AF72-54D9B1CA7E85Q33746483-F8664784-57FF-44DD-9B96-F7B13949FD5AQ33772250-6960B696-A386-4D01-829C-0B64F4F1B64DQ33780466-06DEF43C-C18E-483D-846D-E2BC4C52B94DQ33798175-22E20DD6-235B-4E34-99C0-C6F8301A4905Q33803192-12712AE7-BFC9-4769-A4AD-BE545C212E34Q33828292-956C6272-7D70-4A47-A81A-B0E42FE6CFE9Q33854729-CAAD7B54-70CA-4171-9DDE-C03C549C4CDE
P2860
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.
@en
type
label
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.
@en
prefLabel
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.
@en
P2093
P2860
P50
P1476
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections
@en
P2093
D J Topham
J W Brooks
R D Cardin
P2860
P304
P356
10.1111/J.1600-065X.1997.TB01010.X
P577
1997-10-01T00:00:00Z